A Computational Study About The Mechanism Of Action Of Metformin On Hepatic Gluconeogenesis, Focused On Its Ability To Create Stable Pseudo-Aromatic Copper Complexes
Abstract
Metformin is the best therapeutic choice for treating type 2 Diabetes.\n\nDespite this, and the fact it has been prescribed worldwide for decades, its mechanism of gluconeogenesis inhibition is still unknown.\n\nIn the following work a novel mechanism of inhibition is suggested: that metformin performs its action on the target enzyme not as a pure molecule but, after sequestering endogenous cellular copper, as a copper complex.\n\nThis result was obtained using chemoinformatics methods including homology modeling for the creation of the target enzymes tridimensional virtual structure, molecular docking for both the determination of the movement of the prosthetic group inside its cavity and for the identification of the best ligand poses for the metformin copper complexes, and eventually pharmacophore modeling and virtual screening to find alternative virtual leads that could achieve similar effects.\n\nThe simulations show the complex binding as a non competitive inhibitor to the large exit of the mitochondrial glycerophosphate dehydrogenase enzymes FAD cavity, preventing FAD movement inside the cavity and/or quinone interaction and therefore its electron transfer function.\n\nThe proposed mechanism seems to be successful at explaining a wide range of existing experimental results, both regarding measurements of metformin non-competitive inhibition of GPD2 and the role of copper and pH in its action.\n\nThe virtual screening outcome of at least two similarly active purchasable molecule hints to an easy way to experimentally test the proposed mechanisms.\n\nIn fact, the virtual leads are very similar to the copper complex but quite different from metformin alone, and a laboratory confirmation of their activity should plausibly imply that metformin acts in synergy with copper, giving us the ability to design new antidiabetic drugs in a novel and more rational fashion, with significant savings in research costs and efforts.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- If Metformin Inhibited the Mitochondrial Glycerol Phosphate Dehydrogenase It Might Not Benefit Diabetes
M. J. MacDonald, I.-u. H. Ansari, … S. W. Stoker·bioRxiv·Mar 28, 2020
- Metformin inhibits mitochondrial complex I in intestinal epithelium to promote glycemic control
Zachary L. Sebo, Ram Prosad Chakrabarty, … Navdeep S. Chandel·bioRxiv·Oct 2, 2025
- Structural Basis of Mammalian Respiratory Complex I Inhibition by Medicinal Biguanides
H. R. Bridges, J. N. Blaza, … J. Hirst·bioRxiv·Aug 9, 2022
- A Purinergic Mechanism Underlying Metformin Regulation of Hyperglycemia
J. Senfeld, Q. Peng, … J. Shen·bioRxiv·Sep 27, 2022
- GPRC6A is a Potential Therapeutic Target for Metformin Regulation of Glucose Homeostasis in Mice
Min Pi, Rupesh Agarwal, … L. Darryl Quarles·bioRxiv·Aug 19, 2024
- Antidiabetic effect of 1-deazapurines derivatives with alpha-glucosidase Enzyme: A molecular tools approach
Faiza Boukli Hacene, Sabri Ahmed Cherrak, … Said Ghalem·bioRxiv·Feb 20, 2024